Full-Time

Global Medical Affairs Senior Director

Rhinology and Gastroenterology

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA + 1 more

More locations: Bridgewater Township, NJ, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • MD required.
  • Minimum 8 years’ experience in industry medical affairs.
  • Prior experience in a Global or at least Regional medical affairs role.
  • Prior experience in Immunology/Immune inflammation Medical affairs Life Cycle management.
  • Experience working within an international company with a complex organizational environment; able to operate in a matrix team-oriented structure.
Responsibilities
  • Support the Head of Global Medical Affairs Dupilumab Rhinology and Gastroenterology in the build and execution of Global Med Affairs strategy.
  • Build and execute the Life Cycle management for Dupilumab Rhinology and Gastroenterology including pediatric indication; define and prioritize the future needs including new study ideas and tactics to prioritize the best areas for clinical trial investment.
  • Collaborate with alliance partners at Regeneron: take a team-oriented approach to making sure strategy is clearly defined and consistent with relevant stakeholders in clinical development and commercial teams.
  • Coordinate data gap analyses across the Regions and countries.
  • Establish IEGP plans and supervise the implementation.
  • Collaborate with the Alliance to execute the data generation activities in alignment with the Brand plan and Global Medical Affairs Plan.
  • Lead and supervise analyses from the development program dupilumab for additional publications.
  • Supervise physician/scientist in charge of the execution of the GMA LCM and data generation.
  • Establish and maintain strong relationships with experts in the Rhinology and Gastroenterology field, academics and professionals and/or patient associations. Prior knowledge of and established relationships with key opinion leaders in Rhinology and Gastroenterology considered an asset.
  • Lead advisory boards or roundtables for anti-IL-4/IL-13 in Rhinology and Gastroenterology and gain strategic insights for medical, scientific, and development strategy.
  • Give significant input to publications and co-author relevant abstracts. Drive process of data dissemination and ensure that it is publicly presented in an appropriate and timely fashion and in a fair and balanced manner.
  • Ensure the scientific integrity of sponsored and supported research, information, and relationships with healthcare providers and patient advocacy groups.
  • Ensure a patient-centric approach to development of medical strategy both for product and device development as well as possible services which can enhance the value proposition of the product; Provide relevant feedback to market access teams to ensure optimal pricing and reimbursement strategy and inclusion of relevant endpoints in clinical trials.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse product pipeline and a global presence. The company's goal is to enhance health outcomes and improve the quality of life for individuals worldwide.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Simplify Jobs

Simplify's Take

What believers are saying

  • Tolebrutinib's FDA Breakthrough Therapy designation boosts Sanofi's neurology portfolio.
  • Dupixent's EU approval for young children expands Sanofi's pediatric market.
  • Sanofi's partnership with BrightInsight accelerates digital health solution development.

What critics are saying

  • Liver enzyme elevations in tolebrutinib patients may affect market acceptance.
  • Increased competition in rare diseases from biotech startups challenges Sanofi.
  • Regulatory delays could impact Dupixent's approval for chronic spontaneous urticaria.

What makes Sanofi unique

  • Sanofi's Care4Rare program supports innovative solutions for rare diseases.
  • The MyWay app enhances patient engagement and medication adherence.
  • Sanofi's Muse AI tool optimizes patient recruitment in clinical trials.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Professional Development Budget

Parental Leave